The Enterprise Value as of December 2025 (TTM) for Mural Oncology plc (MURA) is -36538249.00

According to Mural Oncology plc’s latest financial reports and current stock price. The company's current Enterprise Value is -36538249.00. This represents a change of -29.79% compared to the average of -52043168.58 of the last 4 quarters.

Mural Oncology plc (MURA) Historical Enterprise Value (quarterly & annually)

How has MURA Enterprise Value performed in the past?

The mean historical Enterprise Value of Mural Oncology plc over the last ten years is 1.58M. The current -36538249.00 Enterprise Value has changed -231021.02% with respect to the historical average. Over the past ten years (40 quarters), MURA's Enterprise Value was at its highest in in the December 2022 quarter at 102.19M. The Enterprise Value was at its lowest in in the June 2023 quarter at -193465113.60.

Mural Oncology plc (MURA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mural Oncology plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mural Oncology plc (MURA) Average Enterprise Value

How has MURA Enterprise Value performed in the past?

The current Enterprise Value of Mural Oncology plc (MURA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mural Oncology plc (MURA) Enterprise Value vs. Peers

How is MURA’s Enterprise Value compared to its peers?

Mural Oncology plc’s Enterprise Value is less than BioXcel Therapeutics, Inc. (136.96M), less than Generation Bio Co. (71.40M), less than Jasper Therapeutics, Inc. (-7125220.00), less than Evaxion Biotech A/S (29.95M), less than Verrica Pharmaceuticals Inc. (72.93M), less than BioAtla, Inc. (47.72M), less than Veru Inc. (23.71M), less than Liminatus Pharma, Inc. Class A Common Stock (26.51M), less than Alterity Therapeutics Limited (48.31M), less than SAB Biotherapeutics, Inc. (13.08M),

Build a custom stock screener for Mural Oncology plc (MURA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mural Oncology plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mural Oncology plc (MURA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mural Oncology plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.